Prognostic value of splenic volume in hepatocellular carcinoma patients receiving transarterial chemoembolization

Volume: 12, Issue: 3, Pages: 1141 - 1151
Published: Jun 1, 2021
Abstract
Liver function is a key determinant for the survival of hepatocellular carcinoma (HCC) patients receiving transarterial chemoembolization (TACE). However, establishing robust prognostic indicators for liver insufficiencies and patient survival remains an unmet demand. This retrospective study evaluated the prognostic value of splenic volume (SV) in HCC patients undergoing TACE.A total of 67 HCC patients who underwent at least two consecutive...
Paper Details
Title
Prognostic value of splenic volume in hepatocellular carcinoma patients receiving transarterial chemoembolization
Published Date
Jun 1, 2021
Volume
12
Issue
3
Pages
1141 - 1151
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.